PORTAIL DOCUMENTAIRE

Article

Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia : Results From the Prostate Cancer Prevention Trial.

Jeannette-M SCHENK ; Gregory-S CALIP ; Phyllis GOODMAN ; Alan-R KRISTAL ; PARSONS (Jkellogg) : USA. Division of Urologic Oncology. Moores Comprehensive Cancer Center. University of California. San Diego. La Jolla. CA. ; Catherine-M TANGEN ; THOMPSON (Ian-M) : USA. Department of Urology. University of Texas Health Science Center at San Antonio. San Antonio. TX. |

Dans American journal of epidemiology (vol. 176, n° 2, 2012)

[BDSP. Notice produite par INIST-CNRS R0xGIBFI. Diffusion soumise à autorisation]. The authors conducted a cohort study of nonsteroidal antiinflammatory drug (NSAID) use and risk of symptomatic benign prostatic hyperplasia (BPH), using data from[...]

Plus d'information...

Ajouter à ma sélection

Article

Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer : Results from the Prostate Cancer Prevention Trial.

Jeannette-M SCHENK ; Kathryn-B Arnold ; Alan-R KRISTAL ; LIN (Daniel-W) : USA. Department of Urology. University of Washington. Seattle. WA. ; Marian-L NEUHOUSER ; TANGEN (Catherine-M) : USA. Department of Biostatistics. University of Washington. Seattle. WA. ; THOMPSON (Ian-M) : USA. Department of Urology. University of Texas Health Science Center at San Antonio. San Antonio. TX. ; Emily White ; Swog statistical Center. Fred Hutchinson Cancer Research Center. Seattle. WA. USA |

Dans American journal of epidemiology (vol. 173, n° 12, 2011)

[BDSP. Notice produite par INIST-CNRS proIR0xj. Diffusion soumise à autorisation]. This study examined the association between symptomatic benign prostatic hyperplasia (BPH) and prostate cancer risk in 5,068 placebo-arm participants enrolled in [...]

Plus d'information...

Ajouter à ma sélection

Article

Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia : Results From the Prostate Cancer Prevention Trial.

Jeannette-M SCHENK ; Mario KRATZ ; Alan-R KRISTAL ; LIN (Daniel-W) : USA. Department of Urology. University of Washington. Seattle. WA. ; Marian-L NEUHOUSER ; Catherine-M TANGEN ; THOMPSON (Ian-M) : USA. Department of Urology. University of Texas Health Science Center at San Antonio. San Antonio. TX. ; Emily White |

Dans American journal of epidemiology (vol. 171, n° 5, 2010)

[BDSP. Notice produite par INIST-CNRS s7m9R0xt. Diffusion soumise à autorisation]. The authors conducted a nested case-control study of serum inflammatory markers and risk of symptomatic benign prostatic hyperplasia (BPH), using data from the pl[...]

Plus d'information...

Ajouter à ma sélection